Edmund J Pezalla, MD, founder and CEO of Enlightenment Bioconsult, Hartford, CT provides insight on rare disease drug policy noting volume and indication-based contracts as potential solutions for managing costs of therapies.
Edmund J Pezalla, MD, founder and CEO of Enlightenment Bioconsult, Hartford, CT provides insight on rare disease drug policy noting volume and indication-based contracts as potential solutions for managing costs of therapies.
Edmund J Pezalla, MD, founder...